Published in Infect Immun on May 01, 1992
Molecular cloning, mapping, and regulation of Pho regulon genes for phosphonate breakdown by the phosphonatase pathway of Salmonella typhimurium LT2. J Bacteriol (1995) 3.94
Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun (1995) 2.55
Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun (2004) 2.32
Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol (2011) 2.26
Synergistic effect of mutations in invA and lpfC on the ability of Salmonella typhimurium to cause murine typhoid. Infect Immun (1997) 1.98
Vaccination strategies for mucosal immune responses. Clin Microbiol Rev (2001) 1.98
A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect Immun (2000) 1.94
Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev (1998) 1.81
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A (1995) 1.80
Microbiology of bacterial translocation in humans. Gut (1998) 1.75
Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect Immun (1996) 1.74
A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin. Infect Immun (2009) 1.68
Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun (2000) 1.67
Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol (2013) 1.57
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest (2011) 1.53
Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen. Infect Immun (1995) 1.52
Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun (1993) 1.52
Molecular characterization of the oafA locus responsible for acetylation of Salmonella typhimurium O-antigen: oafA is a member of a family of integral membrane trans-acylases. J Bacteriol (1996) 1.39
Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol (1998) 1.37
The role of secretory antibodies in infection immunity. Nat Rev Microbiol (2010) 1.36
Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria. Infect Immun (1996) 1.30
Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect Immun (1995) 1.29
Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice. Infect Immun (1995) 1.20
Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol (2013) 1.19
Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro. Infect Immun (1993) 1.19
Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches. J Virol (2001) 1.17
Inhibition of Salmonella enterica serovar typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. Infect Immun (2008) 1.17
Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect Immun (1996) 1.17
Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies. Infect Immun (1995) 1.15
Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun (2000) 1.15
Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol Lett (2009) 1.11
Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect Immun (1998) 1.10
Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun (2004) 1.09
Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. J Virol (2004) 1.05
Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge. Vaccine (2011) 1.04
Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest (2010) 1.04
Ingested allergens must be absorbed systemically to induce systemic anaphylaxis. J Allergy Clin Immunol (2011) 1.04
Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium. Infect Immun (2003) 1.01
Recognition of gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates. J Biol Chem (2011) 0.98
Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin A antibodies isolated from human breast milk. Infect Immun (2000) 0.98
Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens. Curr Womens Health Rev (2008) 0.98
Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA. Vaccine (2010) 0.95
Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection. Infect Immun (1998) 0.94
Glycoconjugate vaccine strategies for protection against invasive Salmonella infections. Hum Vaccin Immunother (2012) 0.93
In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc Natl Acad Sci U S A (1999) 0.93
Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity. Infect Immun (2008) 0.92
Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination. Infect Immun (2002) 0.92
Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein. Infect Immun (1999) 0.92
Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines. Infect Immun (1999) 0.92
Association of a protective monoclonal IgA with the O antigen of Salmonella enterica serovar Typhimurium impacts type 3 secretion and outer membrane integrity. Infect Immun (2012) 0.91
Independent bottlenecks characterize colonization of systemic compartments and gut lymphoid tissue by salmonella. PLoS Pathog (2014) 0.90
Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not. Antimicrob Agents Chemother (2012) 0.89
Exposure of Salmonella enterica Serovar typhimurium to a protective monoclonal IgA triggers exopolysaccharide production via a diguanylate cyclase-dependent pathway. Infect Immun (2012) 0.87
Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage. Infect Immun (2000) 0.86
Expression, purification and biochemical characterization of recombinant murine secretory component: a novel tool in mucosal immunology. Biochem J (1999) 0.86
Stress modulates intestinal secretory immunoglobulin A. Front Integr Neurosci (2013) 0.86
Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid. PLoS One (2011) 0.86
Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Infect Immun (2013) 0.84
Pathogenicity and protective effect of rough mutants of Salmonella species in germ-free piglets. Infect Immun (1997) 0.84
Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology. Infect Immun (2015) 0.84
Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein. Appl Environ Microbiol (2009) 0.82
A novel surface protein of Trichomonas vaginalis is regulated independently by low iron and contact with vaginal epithelial cells. BMC Microbiol (2006) 0.82
Lipopolysaccharide-specific but not anti-flagellar immunoglobulin A monoclonal antibodies prevent Salmonella enterica serotype enteritidis invasion and replication within HEp-2 cell monolayers. Infect Immun (2002) 0.82
Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis. PLoS One (2013) 0.81
Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice. PLoS One (2014) 0.80
A Cronobacter turicensis O1 antigen-specific monoclonal antibody inhibits bacterial motility and entry into epithelial cells. Infect Immun (2014) 0.77
Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid. PLoS One (2015) 0.77
Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response. Mucosal Immunol (2013) 0.76
High-avidity IgA protects the intestine by enchaining growing bacteria. Nature (2017) 0.76
Intermittent fasting favored the resolution of Salmonella typhimurium infection in middle-aged BALB/c mice. Age (Dordr) (2016) 0.75
Specific Monoclonal Antibody Overcomes the Salmonella enterica Serovar Typhimurium's Adaptive Mechanisms of Intramacrophage Survival and Replication. PLoS One (2016) 0.75
Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants. Front Cell Infect Microbiol (2016) 0.75
Role of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella Typhimurium. PLoS Negl Trop Dis (2016) 0.75
Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa. PLoS Negl Trop Dis (2017) 0.75
The Dynamic Interactions between Salmonella and the Microbiota, within the Challenging Niche of the Gastrointestinal Tract. Int Sch Res Notices (2014) 0.75
Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice. PLoS One (2015) 0.75
Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice. Front Cell Infect Microbiol (2017) 0.75
Gas-filled microbubbles: novel mucosal antigen-delivery system for induction of anti-pathogen's immune responses in the gut. Gut Microbes (2017) 0.75
Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection. Sci Rep (2017) 0.75
A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A (1989) 9.79
Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium. Am J Pathol (1967) 8.61
The route of enteric infection in normal mice. J Exp Med (1974) 7.99
Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods (1985) 5.80
Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol (1990) 4.87
Penetration of Salmonella through a polarized Madin-Darby canine kidney epithelial cell monolayer. J Cell Biol (1988) 4.44
Summary of an international workshop on typhoid fever. Rev Infect Dis (1986) 4.21
Intestinal colonization and virulence of Salmonella in mice. Infect Immun (1978) 3.44
Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study. Microbiol Immunol (1986) 3.04
The structure and function of human IgA. Biochem J (1990) 2.65
Overview of the mucosal immune system. Curr Top Microbiol Immunol (1989) 2.64
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun (1991) 2.14
Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. J Immunol (1983) 1.82
Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol (1989) 1.82
Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis (1986) 1.77
ToxR regulates the production of lipoproteins and the expression of serum resistance in Vibrio cholerae. Proc Natl Acad Sci U S A (1991) 1.72
Molecular mechanisms of immunoglobulin A defense. Annu Rev Microbiol (1989) 1.70
Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58
Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies. J Immunol (1985) 1.16
Immunobiology of IgA. Am J Kidney Dis (1988) 1.10
Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. II. Measurement of intestinal antibodies by radioimmunoassay. Clin Exp Immunol (1981) 1.09
Demonstration of specific IgA in human feces after immunization with live Ty21a Salmonella typhi vaccine. J Infect Dis (1985) 1.08
Systemic and intestinal immunities after natural typhoid infection. J Clin Microbiol (1987) 0.96
Future vaccines against enteric pathogens. Infect Dis Clin North Am (1990) 0.89
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol (1988) 31.85
DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature (2000) 19.93
Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci U S A (1987) 15.50
Lysogenic conversion by a filamentous phage encoding cholera toxin. Science (1996) 15.37
Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature (1984) 12.10
Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein. Cell (1987) 11.04
Coordinate regulation and sensory transduction in the control of bacterial virulence. Science (1989) 10.59
A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A (1989) 9.79
Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med (1988) 9.19
Duplication and amplification of toxin genes in Vibrio cholerae. Cell (1983) 8.53
Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. Proc Natl Acad Sci U S A (1984) 8.47
Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev (1998) 8.36
Selection of bacterial virulence genes that are specifically induced in host tissues. Science (1993) 6.70
Regulatory cascade controls virulence in Vibrio cholerae. Proc Natl Acad Sci U S A (1991) 6.29
Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J Bacteriol (1987) 6.13
Broad-host-range vectors for delivery of TnphoA: use in genetic analysis of secreted virulence determinants of Vibrio cholerae. J Bacteriol (1989) 5.85
In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc Natl Acad Sci U S A (1999) 4.97
Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol (1990) 4.87
Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect Immun (1988) 4.83
Genetics of bacterial enterotoxins. Annu Rev Microbiol (1986) 4.63
TcpP protein is a positive regulator of virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci U S A (1998) 4.35
Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression. Infect Immun (1996) 4.14
Type VI secretion requires a dynamic contractile phage tail-like structure. Nature (2012) 3.88
A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol (1996) 3.88
Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis. J Bacteriol (1988) 3.88
Systematic identification of essential genes by in vitro mariner mutagenesis. Proc Natl Acad Sci U S A (1998) 3.86
An essential role for DNA adenine methylation in bacterial virulence. Science (1999) 3.80
Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U S A (1999) 3.75
Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection. Mol Microbiol (1995) 3.69
Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12. Proc Natl Acad Sci U S A (1982) 3.68
Alkaline phosphatase fusions: sensors of subcellular location. J Bacteriol (1990) 3.59
Hyperactive transposase mutants of the Himar1 mariner transposon. Proc Natl Acad Sci U S A (1999) 3.45
CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc Natl Acad Sci U S A (1993) 3.34
Nucleotide sequence of the type A staphylococcal enterotoxin gene. J Bacteriol (1988) 3.26
Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc Natl Acad Sci U S A (1987) 3.25
Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol Microbiol (1998) 3.24
Regulation, replication, and integration functions of the Vibrio cholerae CTXphi are encoded by region RS2. Mol Microbiol (1997) 3.22
Genetic characterization of a new type IV-A pilus gene cluster found in both classical and El Tor biotypes of Vibrio cholerae. Infect Immun (1999) 3.10
Periplasmic interaction between two membrane regulatory proteins, ToxR and ToxS, results in signal transduction and transcriptional activation. Cell (1991) 3.09
ToxR regulates virulence gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera. Infect Immun (1994) 3.08
Genetic regulation of bacterial virulence. Annu Rev Genet (1989) 2.98
Enzymic activity of cholera toxin. II. Relationships to proteolytic processing, disulfide bond reduction, and subunit composition. J Biol Chem (1979) 2.93
Isolation of enterotoxin structural gene deletion mutations in Vibrio cholerae induced by two mutagenic vibriophages. Proc Natl Acad Sci U S A (1982) 2.92
Affinity filters, a new approach to the isolation of tox mutants of Vibrio cholerae. Proc Natl Acad Sci U S A (1978) 2.89
Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter. J Bacteriol (1989) 2.87
Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle. Mol Microbiol (1998) 2.74
Bacterial infection as assessed by in vivo gene expression. Proc Natl Acad Sci U S A (1997) 2.74
The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Proc Natl Acad Sci U S A (1994) 2.68
Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J Infect Dis (1994) 2.67
Genetic analysis of the cholera toxin-positive regulatory gene toxR. J Bacteriol (1985) 2.59
Staphylococcal enterotoxin A is encoded by phage. Science (1985) 2.57
Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host. Proc Natl Acad Sci U S A (1995) 2.57
Expression of ToxR, the transcriptional activator of the virulence factors in Vibrio cholerae, is modulated by the heat shock response. Proc Natl Acad Sci U S A (1990) 2.56
Simple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae. Infect Immun (1977) 2.56
Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun (1994) 2.56
Confirmation of the Fur operator site by insertion of a synthetic oligonucleotide into an operon fusion plasmid. J Bacteriol (1988) 2.49
Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun (1997) 2.49
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet (1995) 2.43
Roles of DNA adenine methylation in regulating bacterial gene expression and virulence. Infect Immun (2001) 2.42
Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev (1992) 2.39
Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc Natl Acad Sci U S A (1988) 2.38
Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol (2000) 2.36
Morphological studies on fimbriae expressed by Vibrio cholerae 01. Microb Pathog (1988) 2.33
In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J (2000) 2.32
Rearrangement of the bacterial chromosome: forbidden inversions. Science (1988) 2.26
Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun (1990) 2.25
The putative iron transport system SitABCD encoded on SPI1 is required for full virulence of Salmonella typhimurium. Mol Microbiol (2000) 2.24
In vivo genetic analysis of bacterial virulence. Annu Rev Microbiol (1999) 2.23
Regulation of cholera toxin by temperature, pH, and osmolarity. Methods Enzymol (1994) 2.23
Effect of a recA mutation on cholera toxin gene amplification and deletion events. J Bacteriol (1986) 2.22
Use of genetic recombination as a reporter of gene expression. Proc Natl Acad Sci U S A (1994) 2.21
Vibrio parahaemolyticus has a homolog of the Vibrio cholerae toxRS operon that mediates environmentally induced regulation of the thermostable direct hemolysin gene. J Bacteriol (1993) 2.18
Differential patterns of acquired virulence genes distinguish Salmonella strains. Proc Natl Acad Sci U S A (1998) 2.18
Differences in regulatory sequences of naturally occurring JC virus variants. J Virol (1985) 2.17
Vibrio cholerae tolC is required for bile resistance and colonization. Infect Immun (2001) 2.17
Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants. Infect Immun (1978) 2.16
In vivo transduction with shiga toxin 1-encoding phage. Infect Immun (1998) 2.16
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun (1991) 2.14
Cloning of the Vibrio cholerae recA gene and construction of a Vibrio cholerae recA mutant. J Bacteriol (1986) 2.13
TnAraOut, a transposon-based approach to identify and characterize essential bacterial genes. Nat Biotechnol (2000) 2.11
Tissue-specific gene expression identifies a gene in the lysogenic phage Gifsy-1 that affects Salmonella enterica serovar typhimurium survival in Peyer's patches. J Bacteriol (2000) 2.10
Differential regulation of multiple flagellins in Vibrio cholerae. J Bacteriol (1998) 2.09
Single amino acid substitutions in the N-terminus of Vibrio cholerae TcpA affect colonization, autoagglutination, and serum resistance. Mol Microbiol (1995) 2.03
Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic. J Cell Biol (1992) 2.00
Analysis of clinical and environmental strains of nontoxigenic Vibrio cholerae for susceptibility to CTXPhi: molecular basis for origination of new strains with epidemic potential. Infect Immun (1998) 1.99
Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model. J Infect Dis (1990) 1.97
Genetic footprinting with mariner-based transposition in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2000) 1.95
The role of pili and capsule in the pathogenesis of neonatal infection with Escherichia coli K1. J Infect Dis (1983) 1.95
Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect Immun (2000) 1.94
Constitutive sensory transduction mutations in the Bordetella pertussis bvgS gene. J Bacteriol (1992) 1.91
Effects of changes in membrane sodium flux on virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci U S A (1999) 1.90
Cholera toxin: genetic analysis, regulation, and role in pathogenesis. Curr Top Microbiol Immunol (1985) 1.89
Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr (1991) 1.85
Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology (1994) 1.85